Epstein‐barr virus subtype distribution in angioimmunoblastic lymphadenopathy
Epstein‐barr virus subtype distribution in angioimmunoblastic lymphadenopathy
复制标题
DOI:
10.1002/ijc.2910550509
复制
发表时间:
1993-11
影响因子:
6.4
通讯作者:
B. Borisch;Massimo Caioni;N. Hurwitz;C. Dommann-Scherrer;B. Odermatt;E. Waelti;R. Hubert Hubert-R.-Hubert-Hubert-1953014615;R. Kraft;J. Laissue
中科院分区:
文献类型:
--
作者:
B. Borisch;Massimo Caioni;N. Hurwitz;C. Dommann-Scherrer;B. Odermatt;E. Waelti;R. Hubert Hubert-R.-Hubert-Hubert-1953014615;R. Kraft;J. Laissue
The tissues of 16 patients bearing a T‐cell lymphoma of angioimmunoblastic lymphadenopathy type (AILD‐TCL) were investigated for the distribution of Epstein‐Barr virus (EBV) subtypes 1and 2. EBV‐association had been proven in these cases by polymerase chain reaction (PCR) for EBV‐DNA, in situ hybridization (ISH) for EBV‐encoded small nuclear RNAs (EBER) and immunohistology for EBV‐encoded latent membrane protein (LMP). PCR and EBER‐ISH produced mostly identical results, but some cases were positive with only one of the 2 methods employed. LMP was detected in a few large cells of 8/13 cases. Twelve cases were investigated for the distribution of EBV subtypes. One case contained EBV genome of subtype 2, 3 cases contained subtype 1 and 4 cases contained both subtypes. Four cases could not be typed. These finclings suggest that in AILD, as in AIDS‐associated lymphomas and lymphomas of the lethal midline granuloma type, subtype 2 of EBV may occur, perhaps in relation to an immunodysfunction developing progressively in these patients.